FI883628A0 - Kinoloner saosom antibakteriska medel. - Google Patents

Kinoloner saosom antibakteriska medel.

Info

Publication number
FI883628A0
FI883628A0 FI883628A FI883628A FI883628A0 FI 883628 A0 FI883628 A0 FI 883628A0 FI 883628 A FI883628 A FI 883628A FI 883628 A FI883628 A FI 883628A FI 883628 A0 FI883628 A0 FI 883628A0
Authority
FI
Finland
Prior art keywords
kinoloner
saosom
medel
antibacterial
saosom antibacterial
Prior art date
Application number
FI883628A
Other languages
English (en)
Other versions
FI883628A (fi
Inventor
Alexander James Bridges
John Michael Domagala
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI883628A0 publication Critical patent/FI883628A0/fi
Publication of FI883628A publication Critical patent/FI883628A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI883628A 1987-08-07 1988-08-03 Kinoloner saosom antibakteriska medel. FI883628A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/083,532 US4780468A (en) 1987-08-07 1987-08-07 8-trifluoromethyl quinolones as antibacterial agents

Publications (2)

Publication Number Publication Date
FI883628A0 true FI883628A0 (fi) 1988-08-03
FI883628A FI883628A (fi) 1989-02-08

Family

ID=22178934

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883628A FI883628A (fi) 1987-08-07 1988-08-03 Kinoloner saosom antibakteriska medel.

Country Status (12)

Country Link
US (1) US4780468A (fi)
EP (1) EP0302525A3 (fi)
JP (1) JPS6466180A (fi)
KR (1) KR890003735A (fi)
AU (2) AU616422B2 (fi)
DK (1) DK439688A (fi)
FI (1) FI883628A (fi)
NO (1) NO883475L (fi)
NZ (1) NZ225626A (fi)
PH (1) PH24784A (fi)
PT (1) PT88203A (fi)
ZA (1) ZA885546B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88506C (fi) * 1986-07-04 1993-05-25 Chemie Linz Gmbh Foerfarande foer framstaellning av farmaceutiskt anvaendbar 7-diazabicykloalkyl-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-oxo-kinolin-3-karboxylsyra eller karboxylsyraester
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
AU618823B2 (en) * 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US5157128A (en) * 1990-11-30 1992-10-20 Warner-Lambert Company Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
DE69131428T2 (de) * 1990-11-30 2000-01-05 Warner Lambert Co Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe
US5364861A (en) * 1990-11-30 1994-11-15 Warner-Lambert Company Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
DE4301245A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Fluor-trifluormethylbenzoesäure-Derivate
DE4342186A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
CZ12097A3 (en) * 1994-07-18 1997-09-17 Ube Industries Trifluoromethylquinolinecarboxylic acid derivatives and pharmaceutical composition containing thereof
ID16655A (id) * 1996-04-24 1997-10-30 Daiichi Seiyaku Co Turunan-turunan sikloalkilaminometilpirolidina
DE69716962T2 (de) * 1996-08-19 2003-07-03 Ube Industries Verfahren zur herstellung von substituierten trifluorobenzoesäurederivaten und deren ester
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
KR100364226B1 (ko) * 1998-03-18 2003-01-24 주식회사 엘지생명과학 7-할로-1-시클로프로필-6-플루오로-4-옥소-1,4-디히드로-[1.8]나프티리딘-3-카복실레이트의 제조방법
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
KR20020072602A (ko) * 2001-03-12 2002-09-18 (주)인산 기능미의 제조방법
JP3729339B2 (ja) * 2001-10-03 2005-12-21 株式会社サタケ 発芽胚芽米の製造方法
KR100448505B1 (ko) * 2001-11-28 2004-09-13 삼서농업협동조합 발아현미 제조방법
US8022247B2 (en) * 2005-04-06 2011-09-20 Chugai Seiyaku Kabushiki Kaisha Process for production of 2,3,4-trifluoro-5-(iodo or bromo)-benzoic acid
CA2647454A1 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
BRPI0709772B8 (pt) * 2006-03-28 2021-05-25 The Protecter & Gamble Company sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico
US7528264B2 (en) * 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
US8809552B2 (en) * 2011-11-01 2014-08-19 Hoffmann-La Roche Inc. Azetidine compounds, compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB830832A (en) * 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
JPS62108878A (ja) * 1985-11-05 1987-05-20 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体およびその製造方法
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
EP0302525A3 (en) 1990-08-22
DK439688A (da) 1989-02-08
NO883475D0 (no) 1988-08-04
PH24784A (en) 1990-10-30
EP0302525A2 (en) 1989-02-08
NZ225626A (en) 1991-03-26
US4780468A (en) 1988-10-25
PT88203A (pt) 1989-06-30
NO883475L (no) 1989-02-08
AU2006088A (en) 1989-02-09
ZA885546B (en) 1990-03-28
AU8374391A (en) 1991-11-14
JPS6466180A (en) 1989-03-13
AU616422B2 (en) 1991-10-31
KR890003735A (ko) 1989-04-17
FI883628A (fi) 1989-02-08
DK439688D0 (da) 1988-08-05

Similar Documents

Publication Publication Date Title
FI883628A0 (fi) Kinoloner saosom antibakteriska medel.
FI850631L (fi) Antibakteriska medel.
FI851471A0 (fi) Antibakteriska medel.
FI875363A0 (fi) O-substituerade tetrahydropyridinoximer saosom kolinergiska medel.
DE3853662D1 (de) Schädlingsbekämpfungsmittel.
NO884284D0 (no) Pesticider.
FI882742A0 (fi) Vaordande medel och dessa innehaollande kompositioner.
DE3850598T2 (de) Substituierte Di-t-butylphenole.
FI906062A (fi) Anvaendningen av alkylpolyglykosid-ytaktiva medel i skoeljmedelskompositioner.
FI861574A0 (fi) Antibakteriska medel.
FI850632A0 (fi) Antibakteriska medel.
FI851592A0 (fi) Antibakteriska foereningar.
FI852289A0 (fi) Antibakteriska foereningar.
DE3886873T2 (de) Desinfektionsmittel.
FI874164A0 (fi) Behandlade lipidreglerande medel.
FI884107A (fi) Saosom antibakteriella medel anvaendbara 4-oxo-3-kinolin-karboxyl-syror och deras framstaellning.
FI900871A0 (fi) Patoeriseringsbestaendigt medel foer eliminering av syre.
DE3875031T2 (de) Substituierte dibenzocycloheptenimine.
DE3866367D1 (de) Pilzartige herbizide.
DE3763309D1 (de) Antibakterielle 3-halogenvinylglycinwirkstoffe.
NO884360D0 (no) Substituerte 2-metylisoksazolidiner.
FI882809A (fi) Profylaktiskt medel foer kontroll av veneriska sjukdomar.
FI874196A0 (fi) Dx-kodklistermaerke. medel foer att manualisera en automatkameras automatiska funktioner.
FI892304A0 (fi) Medel foer foerhindrande av tillfrysning av en brandpost.
FI884561A0 (fi) Temperaturangivare foer aotnjutbara medel.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY